John M. Kane, MD

The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Departments of Psychiatry and Molecular Medicine, Hempstead, New York; Feinstein Institute for Medical Research, Institute of Behavioral Science, Manhasset, New York

JCP
Academic Highlights

September 17, 2019

Long-acting injectable antipsychotics can be a powerful strategy in helping patients to receive ongoing benefit from treatment. You might think that you have adequately explained this treatment option to...
,
JCP
Original Research

April 23, 2019

Read a study examining if patients in the early phase of schizophrenia would accept LAI antipsychotic treatment.
, , , et al
JCP
Commentary

March 5, 2019

Read expert commentary on guidelines for treatment-resistant schizophrenia (TRS) to make more informed treatment decisions.
, , , et al
JCP
Original Research

December 18, 2018

Could valbenazine help your patients who experience antipsychotic-induced abnormal movements? This follow-up analysis of a phase 3 study provides further insights into the efficacy of valbenazine for tardive dyskinesia...
, , , et al
JCP
Consensus Statement

May 8, 2018

The authors of this consensus statement look at the history of the use of the Abnormal Involuntary Movement Scale in tardive dyskinesia studies and outline the challenges of using...
, , , et al
JCP
Educational Activity

December 27, 2017

JCP
Letter to the Editor

October 25, 2017

, , , et al
JCP
Academic Highlights

October 10, 2017

Is your patient experiencing involuntary movements of the face, torso, or extremities? It could be tardive dyskinesia, a side effect of antipsychotic medications. Explore this CME Academic Highlights activity...
, ,
JCP
Article

September 5, 2017

Early treatment response in adults with acute mania is a good predictor of ultimate response and remission. Read this article by Xiao and colleagues to see if response to...
, , , et al
JCP
Review Article

May 9, 2017

Want to do more than prescribe psychotropic medications for youth with disruptive behaviors? Read this systematic review for the latest research on how digitally-assisted parent training programs are being...
, , , et al
JCP
Meta-Analysis

March 29, 2017

With the advent of second-generation antipsychotics, hopes were high that tardive dyskinesia would all but disappear as a side effect. However, it persists. In this meta-analysis, Carbon et al...
, , , et al
JCP
Meta-Analysis

January 25, 2017

Is your patient showing signs of what might be an early phase of prepsychotic illness? Read this meta-analysis for information on how specific cognitive impairments hold promise for predicting...
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe